As a global pharmaceutical company with a biotech mindset and a proven ability to provide new, life-changing therapies, Ipsen is a leading player in its core therapeutic areas.
2017 registration document
Ipsen : 2018 financial objectives
Group sales growth
> 19.0%
Core operating margin
> 29.0%